Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma

Previous studies have indicated that sarcopenia is associated with poor post‐operative outcomes in liver cancer patients, but the studies are limited by confounding from mixed diseases, retrospective data, and non‐standardized measurement methods. At present, there is no research with both muscle mass and strength as predictors for hepatocellular carcinoma (HCC) outcomes. We studied the impact of sarcopenia on post‐operative outcomes in HCC patients in a cohort study designed according to the European Working Group on Sarcopenia in Older People standards.

[1]  A. Coats,et al.  Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021 , 2021, Journal of cachexia, sarcopenia and muscle.

[2]  A. Viddeleer,et al.  Risk factors for surgery-related muscle quantity and muscle quality loss and their impact on outcome , 2021, European Journal of Medical Research.

[3]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[4]  Masakazu Yamamoto,et al.  Improved Mortality, Morbidity, and Long-Term Outcome After Anatomical Hepatectomy With the Glissonean Pedicle Approach in Patients With Hepatocellular Carcinoma , 2020, Annals of surgery.

[5]  S. Ferretti,et al.  Association of Sarcopenia and Body Composition With Short-term Outcomes After Liver Resection for Malignant Tumors. , 2020, JAMA surgery.

[6]  A. Bauman,et al.  Evidence on Physical Activity and the Prevention of Frailty and Sarcopenia Among Older People: A Systematic Review to Inform the World Health Organization Physical Activity Guidelines. , 2020, Journal of physical activity & health.

[7]  L. Peng,et al.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. , 2020, Journal of the American Medical Directors Association.

[8]  Chih-Long Chang,et al.  Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced‐stage ovarian cancer , 2020, Journal of cachexia, sarcopenia and muscle.

[9]  C. Prado,et al.  Nutrition interventions to treat low muscle mass in cancer , 2020, Journal of cachexia, sarcopenia and muscle.

[10]  A. Montano‐Loza,et al.  Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[11]  Kira L. Newman,et al.  Perioperative Evaluation and Management of Patients with Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[13]  S. Yagi,et al.  Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma , 2017, Annals of surgery.

[14]  M. Visser,et al.  Associations of Sarcopenia Definitions, and Their Components, With the Incidence of Recurrent Falling and Fractures: The Longitudinal Aging Study Amsterdam , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  H. Satoh,et al.  Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  D. Power,et al.  Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer , 2018, Journal of cachexia, sarcopenia and muscle.

[17]  M. Tsujita,et al.  Hematological alterations in protein malnutrition , 2017, Nutrition reviews.

[18]  Guoqing Zhang,et al.  Clinical significance of sarcopenia in the treatment of patients with primary hepatic malignancies, a systematic review and meta-analysis , 2017, Oncotarget.

[19]  M. Maddocks,et al.  Sarcopenia and frailty in chronic respiratory disease , 2017, Chronic respiratory disease.

[20]  M. Nagino,et al.  Surgery-Related Muscle Loss and Its Association with Postoperative Complications After Major Hepatectomy with Extrahepatic Bile Duct Resection , 2017, World Journal of Surgery.

[21]  Khalid Yusoff,et al.  Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study , 2015, The Lancet.

[22]  A. Luciani,et al.  Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma. , 2015, Annals of surgery.

[23]  L. Dawson,et al.  Localized and systemic approaches to treating hepatocellular carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  E. Sharon,et al.  Exploiting the critical perioperative period to improve long-term cancer outcomes , 2015, Nature Reviews Clinical Oncology.

[25]  M. Shimizu,et al.  Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma , 2015, Journal of Gastroenterology.

[26]  Y. Sakamoto,et al.  Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer , 2015, Annals of Surgical Oncology.

[27]  M. Haykowsky,et al.  Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[28]  L. Mccargar,et al.  Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  L. Hutchinson.  Risk factors: Cachexia—skeletal muscle depletion is a prognostic factor , 2013, Nature Reviews Clinical Oncology.

[30]  R. Wolfe,et al.  Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. , 2011, Clinical nutrition.

[31]  L. V. van Loon,et al.  Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes. , 2011, Nutrition reviews.

[32]  D. Fouque,et al.  Use of handgrip strength in the assessment of the muscle function of chronic kidney disease patients on dialysis: a systematic review. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  M. Tarnopolsky,et al.  Creatine for treating muscle disorders. , 2011, The Cochrane database of systematic reviews.

[34]  G. Ercolani,et al.  Trends in Perioperative Outcome After Hepatic Resection: Analysis of 1500 Consecutive Unselected Cases Over 20 Years , 2009, Annals of surgery.

[35]  M. Gonen,et al.  Operative Blood Loss Independently Predicts Recurrence and Survival After Resection of Hepatocellular Carcinoma , 2009, Annals of surgery.

[36]  John A. Cowan,et al.  National trends in the use and outcomes of hepatic resection. , 2004, Journal of the American College of Surgeons.

[37]  R. Parks,et al.  The extent of resection influences outcome following hepatectomy for colorectal liver metastases. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[38]  M. Makuuchi,et al.  One thousand fifty-six hepatectomies without mortality in 8 years. , 2003, Archives of surgery.

[39]  Yuman Fong,et al.  Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade , 2002, Annals of surgery.

[40]  C. Garbe,et al.  Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma , 2000, Melanoma research.